Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"to read" My main reason is that I think TPOXX can help stop the spread of MPX in this country. If it shortens the duration of illness, and illness duration is similar to contagiousness duration, that alone is worth it
We need expanded TPOXX access now. We need an emergency use authorization.
https://typefully.com/grahamwalker/PtkV0yV
HHS Expanding Monkeypox Testing Capacity to Five Commercial Laboratory Companies
This week, the Department of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), began shipping orthopoxvirus tests to five commercial laboratory companies, including the nation’s largest reference laboratories, to quickly increase monkeypox testing capacity and access in every community during the ongoing monkeypox outbreak. The companies include Aegis Science, Labcorp, Mayo Clinic Laboratories, Quest Diagnostics and Sonic Healthcare
Not to mention the anti-vaxer movement... They need the antiviral in massive supplies world wide now. And they need testing.
Has anyone looked at the testing method(s) and who is cashing in on it?
$SIGA only approved Monkey Pox antiviral
https://arstechnica.com/science/2022/08/monkeypox-encephalitis-deaths-probed-as-global-cases-top-25000/
Ars Technica
Monkeypox: 25K cases, a batch of new deaths, and 3 state emergencies
WHO says it's seeing a broad range of illnesses as more people are infected.
Medicines against monkeypox (copied from EU website)
Tecovirimat $SIGA approved anti viral
There is one antiviral treatment against monkeypox authorised in the EU, Tecovirimat.
Tecovirimat is also authorised to treat smallpox and cowpox.
Imvanex
There is one vaccine authorised for use against monkeypox disease in the EU, Imvanex.
Imvanex has been authorised to protect adults from monkeypox disease in the EU since 22 July 2022. It is also authorised to protect people against diseases caused by the vaccinia virus.
These new indications were added to Imvanex's existing authorisation against smallpox, which has been in place in the EU since 2013.
EMA's Committee for Medicinal Products for Human Use (CHMP) began evaluating extending Imvanex's authorisation for use against monkeypox on 27 June 2022.
For more information on the vaccine and its assessment by the CHMP, see Imvanex.
My take on the Press Briefing and all information other sources, including a Danish Study into the Bavarian Nordic Vaccine. The EU prefers TPOXX as the defence against Monkey Pox, and are going to imminently order much larger orders for all EU Countries. There are very many doubts over the Bavarian Nordic
Vaccine effectiveness
SIGA winners
The $SIGA Tigger bounce has started says Poo...
Might be. Looked like they wanted to dip it under $14 the other day though.
https://www.ema.europa.eu/en/events/ema-regular-press-briefing-covid-19-monkeypox
EMA -Antiviral Tecovirimat.......
EMA Says Antiviral Tecovirimat For Monkeypox Should Be Available Shortly In EU In Larger Quantities, After A Joint Procurement Procedure
https://www.benzinga.com/general/biotech/22/09/28732512/ema-says-antiviral-tecovirimat-for-monkeypox-should-be-available-shortly-in-eu-in-larger-quantiti
$SIGA
The authors recommended new mRNA vaccines be developed before monkeypox is declared a pandemic
Paving the way for mRNA MP vaccines BIG Pharma
Read between the lines but here it is!
Those fuckers are getting in the race and before you know it
that's what you want F:D:A
A new monkeypox vaccine is needed to prevent global transmission
https://www.news-medical.net/news/20220901/A-new-monkeypox-vaccine-is-needed-to-prevent-global-transmission.aspx
$SIGA may not be oversold much longer now.
With new problems arriving like MonkeyPox bad news and now this:
https://www.telegraph.co.uk/global-health/science-and-disease/mystery-pneumonia-kills-two-infects-six-argentina/
UNKNOWN PNEUMONIA—Very worrisome—3 people have died, 9 people infected, of which 8 medical workers, are in hospital after developing a “pneumonia of unknown origin”—Argentinian authorities announced. Not COVID or flu.
⚠️UNKNOWN PNEUMONIA—Very worrisome—3 people have died, 9 people infected, of which 8 medical workers, are in hospital after developing a “pneumonia of unknown origin”—Argentinian authorities announced. Not COVID or flu. #ArgentinaPneumonia
— Eric Feigl-Ding (@DrEricDing) September 1, 2022
By @sneweyy https://t.co/UVBnbrbOZA pic.twitter.com/tYH10wTcs0
5) He added that the six patients have had a series of tests for “Covid, cold, influenza of both types A + and B +, Hantavirus and 25 other germs” but no virus has yet been identified. ⚠️
— Eric Feigl-Ding (@DrEricDing) September 1, 2022
Texas reports what may be the first U.S. death from monkeypox
https://www.cnbc.com/2022/08/30/texas-reports-what-may-be-the-first-us-death-from-monkeypox.html
Bottom may be in. I just got out of some of mine. this is usually an indication that we go up.
Geez I hope he's okay!!!!
I just saw this I hope you're okay?????..
Health always has to come first.
Yep, missed that one... heart problms prob gonna quit trading... GLTA
“Brazil receives first batch of tecovirimat to treat monkeypox”
https://olhardigital.com.br/2022/08/29/medicina-e-saude/brasil-recebe-primeiro-lote-de-tecovirimat-para-tratamento-da-variola-dos-macacos/
Baby hospitalized after testing positive for monkeypox
Officials said the infant in Washington State was exposed to the virus by an infected family member and is now being treated with an authorized anti-viral called TPOXX in a Seattle hospital.
If an INFANT is receiving TPOXX therapy in a hospital in Washington, that tells you ALL YOU NEED TO KNOW about risk/ benefit. TPOXX DESERVES IMMEDIATE EUA.
https://abcnews.go.com/WNT/video/baby-hospitalized-testing-positive-monkeypox-88948234
The Palm Springs hospital received both oral and IV forms of the medication on Aug. 22, explained Dr. Claudia Fortiche, manager of the research program at Desert Regional. The oral medication, typically three tablets taken twice a day, is the preferred treatment method, Foriche said, but an IV is available for patients who are experiencing painful mouth lesions that make it difficult to swallow. Once a patient is able to swallow, the CDC recommends that they switch to the oral form, Foriche said.
https://eu.desertsun.com/story/news/health/2022/08/26/desert-regional-medical-center-now-providing-tpoxx-medication-monkeypox-infections/7905491001/
$SIGA
A UC Davis Health study finds that the antiviral tecovirimat appears to be safe and effective for the treatment of monkeypox symptoms and skin lesions. The study is one of the earliest studies to assess and report the outcomes of treating patients with monkeypox with this antiviral.
https://health.ucdavis.edu/coronavirus/news/headlines/uc-davis-health-study-reports-on-the-safety-efficacy-of-tecovirimat-in-treating-monkeypox/2022/08
Brazil's health agency just approved the exemption to register to import Tpoxx.
https://www.plenglish.com/news/2022/08/26/anvisa-authorizes-use-of-vaccine-and-drug-against-monkeypox-in-brazil/
Monkeypox medicine tecovirimat will be available in New Zealand from late September.
https://www.1news.co.nz/2022/08/26/monkeypox-medicine-secured-by-govt-for-late-september/
That is a huge range today Day Range: low 17.78 - 21.16 high like a $3.5/share span...
It may track the Bio-tech/Drug firm and Nasdaq indexes in part... I the market wide drop and Bio-tech-drug stop drop was double hit, with over bought got us down this far. Short today and many be Friday may be good short term buys for 1-2 day bounce at a minimum...
Shorts will want cover on Wednesday next week, unless news presses them to cover.
https://www.jpost.com/health-and-wellness/coronavirus/article-715514
The Jerusalem Post | JPost.com
Man tests positive for COVID-19, monkeypox and HIV all at once
It is as of yet unclear if monkeypox, SARS-CoV-2 and HIV co-infection aggravate the patient's condition. They must be joking.
Harris Count jail inmate just tested positive for Monkey Pox. So, it is now an issue for jails, and Hospitals will be needing to watch for carriers...
3 Kids in Georgia also tested positive this week for Monkey Pox
10:1 PE is $9.00
20:1 PE is $18.00 historical
Earnings will see a huge jump on the financials
We could see the bottom today or friday, before a huge bounce. With out more news.
With News $36-$37 could be the next highs
Gonna Rip, but its gonna dip to about 10 before it does. Only because September is coming and its historically the worst month for the stock market.
No, not rebounding like it was
Me too. Second drop here was a not anticipated though.
https://www.barchart.com/stocks/quotes/SIGA/cheat-sheet
No idea...added more
How low will she go? Lol!
All the cards in this game haven’t been played yet!
Why do you say that ? Just because of the drop ?
The whole Biotech sector is down today, index funds IMO. In the news 3 kids in Georgia reported to have Monkeypox today.
I will adding the gifts on these dips.
That was the dip opp for today imo...GLTA
Awesome DD , please keep it coming. $SIGA could be the next Moderna $100 land share price monster...
They have started enrollment on a clinical trial of TPOXX in the UK. The name of the trial is PLATINUM.
https://platinumtrial.ox.ac.uk
$SIGA winner
VCU Medical Center lowers barriers to access monkeypox treatment Tpoxx
Removing obstacles facing our community
August 22, 2022
$SIGA
https://www.vcuhealth.org/news/vcu-medical-center-lowers-barriers-to-access-monkeypox-treatment
The PLATINUM trial, funded by a 3.7 million pound ($4.35 million) UK government grant, aims to recruit at least 500 participants. Participants will either be given a 14-day course of tecovirimat twice daily, or a placebo.
To assess the drug's effectiveness, the rate at which lesions heal, the time taken until patients test negative for the virus, and the proportion of patients who require hospitalisation due to complications will be tracked.
"I'm hoping that we can have a result before Christmas, but it depends on the rate of recruitment," said Sir Peter Horby, Professor of Emerging Infections and Global Health at the University of Oxford and the director of the new Pandemic Sciences Institute.
https://www.reuters.com/business/healthcare-pharmaceuticals/british-scientists-behind-key-covid-trial-launch-study-test-monkeypox-treatment-2022-08-23/?taid=6304afb3b596c2000132a321&utm_campaign=trueanthem&utm_medium=trueanthem&utm_source=twitter
August 22, 2022 huge$
Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection
https://jamanetwork.com/journals/jama/fullarticle/2795743?guestAccessKey=300cc546-00c4-47df-99d6-0a606da1e210&utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jama&utm_content=olf&utm_term=082222
$SIGA winner
Followers
|
49
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1361
|
Created
|
09/25/06
|
Type
|
Free
|
Moderators |
SIGA Technologies, Inc. (Nasdaq: SIGA) is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Our lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |